首页-Anqing Huinyibi Pharmaceutical Co., Ltd

Other products in the pipeline for ophthalmic and autoimmune diseases treatment

time：2022-05-05

author：

reading 31次

Previous:Start a New Journey and Strive for the Future

Next:Non-VEGF inhibitors independently developed by the company

Information recommendation

Employees of Ewon Biotech Pharmaceutical Co., Ltd. Watched the 80th Anniversary Commemoration of the Victory in the War of Resistance Against Japanese Aggression
2025-09-03
Ewon Biotech Pharmaceutical Co., Ltd. Made a Stunning Debut at the 1st "Great Huangshan + Bozhou" North-South Docking Conference on Traditional Chinese Medicine Health Industry
2025-08-04
Ewon Biotech Co., Ltd. Successfully Held the 2025 Semi-annual Work Summary and Commendation Meeting at Anhui Pharmaceutical
2025-07-19
Ewon Biotech Fuzhou Pharmaceutical and Dongfu Pharmaceutical Jointly Conducted Post-Spring Festival Resumption of Work and Production Safety Training
2025-02-09